In the wake of Unigene’s move to file for Chapter 7 bankruptcy earlier this year, a new biotechnology company has emerged to support research and development, led by some members of Unigene’s management team. Enteris Biopharma will use its oral drug delivery platform to help drug developers increase the solubility and absorption of peptides and […]
A fair few venture capital firms and/or their partners are blogging these days. With the new rules on advertising courtesy of the U.S. Securities and Exchange Commission we could see more of that. Motives differ from brand promotion to offering new ways to communicate with entrepreneurs and potential investors. But there will continue to be […]
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
The number of initial public offerings by healthcare companies accounted for about 11 of the 22 IPOS in the second quarter. Still, venture-backed merger and acquisition activity has been sluggish in this sector for the quarter. But in its quarterly earnings call with analysts, Safeguard Scientifics CEO Stephen Zarrilli expressed guarded optimism about having some […]
CVRx, a Minneapolis-based firm that has developed proprietary implantable technology for the treatment of high blood pressure and heart failure, has raised $29.6 million for advancing clinical trials of its Barostim Neo, as well as expanding commercial activities abroad. Johnson & Johnson Development Corp. and New Enterprise Associates, Inc. were the co-lead investors. According to […]
Cellular engineering, precision medicine, and using G protein-coupled receptors to treat heart failure and other conditions. That’s the focus of the three biotechnology companies that made the top 10 for venture investment deals last quarter. Biotechnology was the second largest sector for investment with $1.3 billion going into 103 deals, a 41 percent increase, according […]
Angel investment networks tend to stick to metropolitan cities on the East Coast and West Coast. Why? Most angels see themselves as philanthropic investors and want to invest locally. Startups tend to sprout in places that encourage entrepreneurship and reward it. Traditionally, that has been in cities on the coasts but that is beginning to […]
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
At a recent FundingPost event gathering together investors and entrepreneurs in Philadelphia, crowdfunding, provisions in the JOBS Act, and angel and venture investment trends were on attendee minds. It’s an interesting time to talk about funding opportunities for startups, particularly in Pennsylvania. Gov. Tom Corbett signed a bill last week for a tax credit program […]
One of the ongoing debates among investors is whether geography matters. I have often heard that West Coast angel investors are pretty flexible about where they live in proximity to their investments. Then there are East Coast angels, who like to invest within commuting distance. Backing that argument is Excelerate Health Ventures. The angel investment […]
Safeguard Scientifics has hired a a venture partner with a background steeped in early stage healthcare IT and technology companies. It’s the first addition following the venture firm’s restructuring plans announced last month. Albert Wiegman comes from HLM Venture Partners in Boston. Among the portfolio companies where he served on the board were Soteira, Linkwell […]
The money is still out there, but don’t take it until you absolutely have to. That was the advice to healthcare startups from Fahd M.T. Riaz, a partner in Morgan Lewis’s Business and Finance Practice. He talked about trends in funding for healthcare startups on a panel at CONVERGE with Kelly Campbell Slone of the […]
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
GE's Hammer: If I see a cap table fragmented with a bunch of investors I run in the other direction #mcCONVERGE #crowdfunding — Veronica M. Combs (@vmcombs) July 10, 2013 At the funding panel discussion Wednesday at CONVERGE, a serial entrepreneur asked about crowdfunding. First we got the stock answer of “don’t see how it’s […]
An investment manager named for its knack for adapting to shifting market conditions, has raised $53.5 million for a hedge fund, according to an amended Form D filed with the U.S. Securities and Exchange Commission. Iguana Healthcare Partners takes long and short bets in publicly traded healthcare companies. Although the healthcare sector seemed ready to […]
As Philadelphia-based Drexel University prepares to open its school of entrepreneurship this fall, it has launched a venture arm to identify and cultivate entrepreneurs in its community. Drexel Ventures will manage an innovation fund to provide pre-seed investment in companies at the proof-of-concept stage. It is also rolling out an incubator to support startups and […]
Feeling good about the U.S. Supreme Court ruling on Myriad Genetics that prevents genes from being patented? You may want to rethink it. Although the decision may have paved the way for more open research, but in the long term it may also lead to some unintended consequences. Investors will shy away from primary research […]
The executive vice president who led the capital deployment team at Safeguard Scientifics has resigned as the investment firm goes through a re-organization initiated by CEO Stephen Zarrilli, according to a statement from the company. Zarrilli was named CEO in November. Jim Datin’s resignation is scheduled to take effect June 30. Datin joined Safeguard in […]